← Back to front page
Oceania · General news · The West Australian

Viridis pockets US$5M at premium for Brazilian rare earths

Published by The West Australian · Australia 17 h ago
Camera IconViridis Mining and Minerals mixed rare earths demonstration processing plant in Minas Gerais, Brazil. Credit: File
Camera IconViridis Mining and Minerals mixed rare earths demonstration processing plant in Minas Gerais, Brazil. Credit: File · The West Australian

Detailed summary

Viridis Mining and Minerals has pocketed a second US$5 million tranche from a Vale-backed Brazilian critical minerals fund, issuing shares at a 17 per cent premium to advance its…

Viridis Mining and Minerals has pocketed a second US$5 million tranche from a Vale-backed Brazilian critical minerals fund, issuing shares at a 17 per cent premium to advance its Colossus project.

The funding has come from the ORE Régia FIP Critical Minerals Fund, which is anchored by Brazilian mining goliath Vale and the nation’s development bank investment arm, BNDESPAR. The injection forms part of an existing US$30 million (A$44.4M) binding agreement and was settled through the issue of just over 2 million new shares at a price of A$3.40 each.

The ORE Régia fund, with an estimated R$1 billion (A$261M) under management, was recently created to accelerate strategically important mineral projects in Brazil. Its selection of Colossus as its first investment would appear to underscore the project’s national significance.

The latest US$5 million (A$7.4M) payment is the second tranche of a US$30 million (A$44.4M) agreement first executed in November 2025. With a further US$20 million (A$29.6M) still to come from the fund, Viridis looks to have some serious Brazilian institutional muscle in its corner.

The funding significantly de-risks the development pathway for the company’s aptly named Colossus project. A definitive feasibility study has already put some serious numbers around the rare earths prize, delivering a whopping net present value of US$719 million (A$1.06 billion) against a development price tag of US$449 million (A$664.4 million). Viridis is targeting a funding mix of about 70 per cent senior debt and 30 per cent equity to cover the pre-production costs.

The company says its pro forma cash and equity funding now sits at about US$141 million (AU$209M). This figure more than covers the indicative equity requirement of US$133 million (A$197M), leaving it with a potential surplus of about US$8 million (A$11.84 million) for working capital.

The latest funding follows the company’s recent binding offtake agreement with European chemical heavyweight Solvay.

With its…

Oper…

Opening of the article, excerpted from The West Australian. To read the rest, open the article on the publisher's site.

Read the full article on The West Australian Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (thewest.com.au)

Also worth reading